News | May 18, 2021
Outlook promising for Cipla: HDFC Securities
The outlook for the US business remains good as respiratory pipeline (gAbraxane, gAdvair, gDulera) adds medium-term growth visibility.
The outlook for the US business remains good as respiratory pipeline (gAbraxane, gAdvair, gDulera) adds medium-term growth visibility.
India sales grew 23.5% YoY with consolidation of Wockhardt products
Aarti Drugs has reported total income of Rs.2159.30 crores during the 12 months period ended March 31, 2021
Dr. Reddy's Laboratories has reported total income of Rs.19338.9 crores during FY ended March 31, 2021
The trial met its pre-specified primary endpoint, demonstrating that PDP-716 dosed once daily is equivalent to Alphagan P 0.1% dosed 3 times a day
The tablets will be manufactured and marketed under Vivimed’s brand name “Favulous” across India
R&D Centre will be housed in Baddi and will cater to all business divisions in addition to expansion plans for all its verticals including APls, Formulations and Medical Devices
The companyreported total income of Rs.2915.67 crores during the 12 months period ended March 31, 2021
Gujarat Themis Biosyn has reported total income of Rs.93.82 crores for FY 2020-21
These media reports are based on incorrect facts and are without any basis.
Subscribe To Our Newsletter & Stay Updated
